View Financial HealthPsyence Group 배당 및 자사주 매입배당 기준 점검 0/6Psyence Group 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-535.7%자사주 매입 수익률총 주주 수익률-535.7%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공지 • Dec 02Psyence Group Inc., Annual General Meeting, Jan 30, 2026Psyence Group Inc., Annual General Meeting, Jan 30, 2026.공지 • Aug 23Psyence Group Inc. (CNSX:PSYG) signed a letter of intent to acquire Gold Coast Resources Inc.Psyence Group Inc. (CNSX:PSYG) signed a letter of intent to acquire Gold Coast Resources Inc on August 22, 2025. It is anticipated that the Acquisition will be completed by way of a three-corner amalgamation or similar transaction under the Business Corporations Act (Ontario), pursuant to which a wholly owned subsidiary of Psyence will amalgamate with Gold Coast Resources and each issued and outstanding common share of the Gold Coast Resources will be exchanged for one common share of the resulting issuer ("Resulting Issuer Share"). Convertible securities of the Gold Coast Resources will be exchanged on the same basis. The exchange ratio refers to post-consolidation shares of Psyence Group Inc., if applicable. Pursuant to the LOI, Psyence will advance a secured loan to GoldCoast bearing interest at 10% per annum, maturing on the earlier of the closing of the Acquisition and December 31, 2025, and secured against all assets of GoldCoast. The use of proceeds of the Loan will be for the preparation and submission of the application for the exploration license as well as the preparation of the NI 43-101 Qualified Persons report. The Acquisition is subject to execution of a definitive agreement, completion of satisfactory due diligence by each party, receipt of all required corporate, shareholder and regulatory approvals and other customary closing conditions. Following closing, the board of directors and senior management of the Resulting Issuer will be reconstituted to include nominees of Gold Coast Resources.공지 • Jun 19Psyence Group Inc. announced that it expects to receive CAD 0.6 million in fundingPsyence Group Inc. announces a non-brokered private placement to issue 6,000,000 common shares at a price of CAD 0.10 per share for gross proceeds of CAD 600,000 on June 18, 2025. The Offering is expected to close on or about June 25, 2025, or such other date as the Company may determine, and is subject to certain conditions, including receipt of all necessary regulatory approvals. No finder’s fees or commissions will be payable in connection with the Offering. The Offering is expected to close on or about June 25, 2025.공지 • Oct 15Psyence Group Inc., Annual General Meeting, Dec 16, 2024Psyence Group Inc., Annual General Meeting, Dec 16, 2024.공지 • Apr 06Psyence Group Inc., Annual General Meeting, Jun 07, 2024Psyence Group Inc., Annual General Meeting, Jun 07, 2024.공지 • Mar 27An undisclosed buyer completed the acquisition of Mind Health (Pty) Ltd and Psyence Uk Group Ltd from Psyence Group Inc. (CNSX:PSYG).An undisclosed buyer entered into a conditional agreement to acquire Mind Health (Pty) Ltd and Psyence Uk Group Ltd from Psyence Group Inc. (CNSX:PSYG) for CAD 1 million on March 11, 2024. The transaction is approved by the board and is subjected to certain closing conditions.An undisclosed buyer completed the acquisition of Mind Health (Pty) Ltd and Psyence Uk Group Ltd from Psyence Group Inc. (CNSX:PSYG) on March 26, 2024. Psyence is pleased that the conditions to implement the transaction have been met.공지 • Nov 21Psyence Group Inc. Announces Resignation of Marvin Singer as Board MemberPsyence Group Inc. announced that Mr. Marvin Singer has resigned from his position as a Non-Executive Director for personal reasons. Mr. Singer has been an integral part of the board of the Company since listing in January 2021, providing valuable insights and guidance during his tenure.공지 • Oct 31Psyence Group Inc. announced that it has received CAD 0.162697 million in fundingPsyence Group Inc. announced a private placement of 1,355,810 common shares at a price of CAD 0.12 per unit for the gross proceeds of CAD 162,697 on October 30, 2023. The transaction included participation from returning individual investors, Brandon Kerzner and Cody Futeran. As a part of the transaction, the company also issued 2,467 common shares at a price of CAD 0.12 per common share as payment of a finder's fee of CAD 296.공지 • Jul 12Psyence Group Inc. Appoints Christopher Bull to Board of DirectorsPsyence Group Inc. announced the appointment of Christopher Bull to the board of directors of the Company effective immediately. Mr. Bull is a qualified chemical engineer, attorney, patent attorney and Certified Licensing Professional®. Over his 30-year career Mr. Bull has been an investor, director, founder, and advisor to a range of successful companies in Europe and North America with novel technologies in the fields of pharmaceuticals, biotechnology, food sciences, chemical processing, and extraction technologies. He is recognized for his skills in relation to the development and execution of venture capital investment, patent and intellectual property strategies for high-technology companies and has received a number of international awards in recognition hereof.공지 • Jan 25Psyence Group Inc. Appoints AC Braddock to Scientific Advisory BoardPsyence Group Inc. appointed AC Braddock, CEO of Eden Labs, to its Scientific Advisory Board to utilize her skill sets in methodology and product development.공지 • Jan 24Psyence Group Inc., Annual General Meeting, Mar 09, 2023Psyence Group Inc., Annual General Meeting, Mar 09, 2023.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 PSYG.F 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: PSYG.F 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Psyence Group 배당 수익률 vs 시장PSYG.F의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (PSYG.F)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.2%업계 평균 (Biotechs)2.5%분석가 예측 (PSYG.F) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 PSYG.F 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 PSYG.F 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 PSYG.F 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: PSYG.F 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/02/07 05:17종가2025/11/10 00:00수익2025/09/30연간 수익2025/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Psyence Group Inc.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Ryan HamptonHannam & Partners (Advisory) LLP
공지 • Dec 02Psyence Group Inc., Annual General Meeting, Jan 30, 2026Psyence Group Inc., Annual General Meeting, Jan 30, 2026.
공지 • Aug 23Psyence Group Inc. (CNSX:PSYG) signed a letter of intent to acquire Gold Coast Resources Inc.Psyence Group Inc. (CNSX:PSYG) signed a letter of intent to acquire Gold Coast Resources Inc on August 22, 2025. It is anticipated that the Acquisition will be completed by way of a three-corner amalgamation or similar transaction under the Business Corporations Act (Ontario), pursuant to which a wholly owned subsidiary of Psyence will amalgamate with Gold Coast Resources and each issued and outstanding common share of the Gold Coast Resources will be exchanged for one common share of the resulting issuer ("Resulting Issuer Share"). Convertible securities of the Gold Coast Resources will be exchanged on the same basis. The exchange ratio refers to post-consolidation shares of Psyence Group Inc., if applicable. Pursuant to the LOI, Psyence will advance a secured loan to GoldCoast bearing interest at 10% per annum, maturing on the earlier of the closing of the Acquisition and December 31, 2025, and secured against all assets of GoldCoast. The use of proceeds of the Loan will be for the preparation and submission of the application for the exploration license as well as the preparation of the NI 43-101 Qualified Persons report. The Acquisition is subject to execution of a definitive agreement, completion of satisfactory due diligence by each party, receipt of all required corporate, shareholder and regulatory approvals and other customary closing conditions. Following closing, the board of directors and senior management of the Resulting Issuer will be reconstituted to include nominees of Gold Coast Resources.
공지 • Jun 19Psyence Group Inc. announced that it expects to receive CAD 0.6 million in fundingPsyence Group Inc. announces a non-brokered private placement to issue 6,000,000 common shares at a price of CAD 0.10 per share for gross proceeds of CAD 600,000 on June 18, 2025. The Offering is expected to close on or about June 25, 2025, or such other date as the Company may determine, and is subject to certain conditions, including receipt of all necessary regulatory approvals. No finder’s fees or commissions will be payable in connection with the Offering. The Offering is expected to close on or about June 25, 2025.
공지 • Oct 15Psyence Group Inc., Annual General Meeting, Dec 16, 2024Psyence Group Inc., Annual General Meeting, Dec 16, 2024.
공지 • Apr 06Psyence Group Inc., Annual General Meeting, Jun 07, 2024Psyence Group Inc., Annual General Meeting, Jun 07, 2024.
공지 • Mar 27An undisclosed buyer completed the acquisition of Mind Health (Pty) Ltd and Psyence Uk Group Ltd from Psyence Group Inc. (CNSX:PSYG).An undisclosed buyer entered into a conditional agreement to acquire Mind Health (Pty) Ltd and Psyence Uk Group Ltd from Psyence Group Inc. (CNSX:PSYG) for CAD 1 million on March 11, 2024. The transaction is approved by the board and is subjected to certain closing conditions.An undisclosed buyer completed the acquisition of Mind Health (Pty) Ltd and Psyence Uk Group Ltd from Psyence Group Inc. (CNSX:PSYG) on March 26, 2024. Psyence is pleased that the conditions to implement the transaction have been met.
공지 • Nov 21Psyence Group Inc. Announces Resignation of Marvin Singer as Board MemberPsyence Group Inc. announced that Mr. Marvin Singer has resigned from his position as a Non-Executive Director for personal reasons. Mr. Singer has been an integral part of the board of the Company since listing in January 2021, providing valuable insights and guidance during his tenure.
공지 • Oct 31Psyence Group Inc. announced that it has received CAD 0.162697 million in fundingPsyence Group Inc. announced a private placement of 1,355,810 common shares at a price of CAD 0.12 per unit for the gross proceeds of CAD 162,697 on October 30, 2023. The transaction included participation from returning individual investors, Brandon Kerzner and Cody Futeran. As a part of the transaction, the company also issued 2,467 common shares at a price of CAD 0.12 per common share as payment of a finder's fee of CAD 296.
공지 • Jul 12Psyence Group Inc. Appoints Christopher Bull to Board of DirectorsPsyence Group Inc. announced the appointment of Christopher Bull to the board of directors of the Company effective immediately. Mr. Bull is a qualified chemical engineer, attorney, patent attorney and Certified Licensing Professional®. Over his 30-year career Mr. Bull has been an investor, director, founder, and advisor to a range of successful companies in Europe and North America with novel technologies in the fields of pharmaceuticals, biotechnology, food sciences, chemical processing, and extraction technologies. He is recognized for his skills in relation to the development and execution of venture capital investment, patent and intellectual property strategies for high-technology companies and has received a number of international awards in recognition hereof.
공지 • Jan 25Psyence Group Inc. Appoints AC Braddock to Scientific Advisory BoardPsyence Group Inc. appointed AC Braddock, CEO of Eden Labs, to its Scientific Advisory Board to utilize her skill sets in methodology and product development.
공지 • Jan 24Psyence Group Inc., Annual General Meeting, Mar 09, 2023Psyence Group Inc., Annual General Meeting, Mar 09, 2023.